Internal Medicine · Caguas, PR
NPI
1699785741
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Ave Munoz Marin I 17 Urb Villa Carmen
Caguas, PR, 00726
Phone (787) 746-6466
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
12,650 prescriptions
Company payments, 2025
$35
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Wallace Belmont Rodriguez prescribed most often to Medicare patients was Famotidine, with 932 prescriptions and refills. In total Wallace Belmont Rodriguez wrote 12,650 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Famotidine Generic | 932 | 1,220 | 191 | $7,179 |
| Atorvastatin Calcium Generic | 867 | 2,548 | 263 | $11K |
| Losartan Potassium Generic | 594 | 1,717 | 180 | $8,599 |
| Synthroid Levothyroxine Sodium | 490 | 946 | 95 | $44K |
| Amlodipine Besylate Generic | 350 | 957 | 103 | $1,932 |
| Glyxambi Empagliflozin/Linagliptin | 340 | 358 | 43 | $222K |
| Pantoprazole Sodium Generic | 312 | 452 | 67 | $2,724 |
| Simvastatin Generic | 283 | 823 | 84 | $2,677 |
| Gabapentin Generic | 263 | 634 | 78 | $2,965 |
| Diclofenac Sodium Generic | 244 | 255 | 71 | $4,531 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 218 | 267 | 41 | $20K |
| Metoprolol Succinate Generic | 212 | 602 | 72 | $3,886 |
| Alendronate Sodium Generic | 208 | 256 | 33 | $1,370 |
| Tamsulosin Hcl Generic | 198 | 453 | 50 | $2,383 |
| Xarelto Rivaroxaban | 196 | 222 | 29 | $127K |
Brand drugs: 2,509 claims; generic drugs: 9,897 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wallace Belmont Rodriguez $35 ($35 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $35.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.